Marsavela G, Lee J, Calapre L, Wong SQ, et al. Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy. Clin Cancer Res 2020 Oct 16. pii: 1078-0432.CCR-20-2251.
PMID: 33067256